326
Views
7
CrossRef citations to date
0
Altmetric
Review

Effects of Parkinson’s on employment, cost of care, and quality of life of people with condition and family caregivers in the UK: a systematic literature review

, &
Pages 321-333 | Published online: 21 Oct 2019

References

  • Parkinson’s UK. The incidence and prevalence of Parkinson’s in the UK: results from the Clinical Practice Research Datalink-Reference Report; 2017 Available from: https://www.parkinsons.org.uk/sites/default/files/2018-01/Prevalence%20%20Incidence%20Report%20Latest_Public_2.pdf Accessed 521, 2019.
  • Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord. 2015;30(12):1591–1601. doi:10.1002/mds.2642426474316
  • Schrag A, Horsfall L, Walters K, Noyce A, Petersen I. Prediagnostic presentations of Parkinson’s disease in primary care: a case-control study. Lancet Neurol. 2014;14(1):57–64. doi:10.1016/S1474-4422(14)70287-X25435387
  • Baker MG, Graham L. The journey: Parkinson’s disease. Bmj. 2004;329:611–614. doi:10.1136/bmj.329.7466.61115361447
  • Caslake R, Taylor K, Scott N, et al. Age-, gender-, and socioeconomic status-specific incidence of Parkinson’s disease and parkinsonism in North East Scotland: the PINE study. Parkinsonism Relat Disord. 2013;19(5):515–521. doi:10.1016/j.parkreldis.2013.01.01423462482
  • Wickremaratchi MM, Perera D, O’Loghlen C, et al. Prevalence and age of onset of Parkinson’s disease in Cardiff: a community based cross sectional study and meta-analysis. J Neurol Neurosurg Psychiatry. 2009;80(7):805–807. doi:10.1136/jnnp.2008.16222219531689
  • Horsfall L, Petersen I, Walters K, Schrag A. Time trends in incidence of Parkinson’s disease diagnosis in UK primary care. J Neurol. 2013;260(5):1351–1357. doi:10.1007/s00415-012-6804-z23263597
  • Williamson C, Simpson J, Murray C. Caregivers’ experiences of caring for a husband with Parkinson’s disease and psychotic symptoms. Soc Sci Med. 2008;67:583–589. doi:10.1016/j.socscimed.2008.04.01418524445
  • Hawker S, Payne S, Kerr C, Hardey M, Powell J. Appraising the evidence: reviewing disparate data systematically. Qual Health Res. 2002;12(9):1284–1299. doi:10.1177/104973230223825112448672
  • Politis M, Wu K, Molloy S, Bain PG, Chaudhuri KR, Piccini P. Parkinson’s disease symptoms: the patient’s perspective. Mov Disord. 2010;25(11):1646–1651. doi:10.1002/mds.2313520629164
  • Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N. The Parkinson’s Disease Questionnaire (PDQ-39): development and validation of a Parkinson’s disease summary index score. Age Ageing. 1997;26(5):353–357. doi:10.1093/ageing/26.5.3539351479
  • Rahman S, Griffin HJ, Quinn NP, Jahanshahi M. Quality of life in Parkinson’s disease: the relative importance of the symptoms. Mov Disord. 2008;23(10):1428–1434. doi:10.1002/mds.2166718543333
  • Blackwell AD, Brown VJ, Rochow SB. Quality of life in Parkinson’s disease: movement disorders clinic vs general medical clinic – a comparative study. Scott Med J. 2005;50(1):18–20. doi:10.1177/00369330050500010715792382
  • Leroi I, Ahearn DJ, Andrews M, Mcdonald KR, Byrne EJ, Burns A. Behavioural disorders, disability and quality of life in Parkinson’s disease. Age Ageing. 2011;40:614–621. doi:10.1093/ageing/afr07821788252
  • Findley L, Eichhorn T, Janca A, et al. Factors impacting on quality of life in Parkinson’s disease: results from an international survey. Mov Disord. 2002;17(1):60–67. doi:10.1002/mds.1001011835440
  • Duncan GW, Khoo TK, Yarnall AJ, et al. Health-related quality of life in early Parkinson’s disease: the impact of nonmotor symptoms. Mov Disord. 2014;29(2):195–202. doi:10.1002/mds.2566424123307
  • Simpson J, Lekwuwa G, Crawford T. Predictors of quality of life in people with Parkinson’s disease: evidence for both domain specific and general relationships. Disabil Rehabil. 2014;36(23):1964–1970. doi:10.3109/09638288.2014.88344224499208
  • Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001;33(5):337–343. doi:10.3109/0785389010900208711491192
  • Shearer J, Green C, Counsell CE, Zajicek JP. The impact of motor and non motor symptoms on health state values in newly diagnosed idiopathic Parkinson’s disease. J Neurol. 2012;259(3):462–468. doi:10.1007/s00415-011-6202-y21818689
  • Benharoch J, Wiseman T. Participation in occupations: some experiences of people with Parkinson’s disease. Br J Occup Ther. 2004;67(9):380–387. doi:10.1177/030802260406700902
  • Simpson J, Haines K, Lekwuwa G, Wardle J, Crawford T. Social support & psychological outcome in people with Parkinson’s disease: evidence for a specific pattern of associations. Br J Clin Psychol. 2006;45(4):585–590. doi:10.1348/014466506X9649017076966
  • Barrow CJ, Charlton GS. Coping and self-help group membership in Parkinson’s disease: an exploratory qualitative study. Health Social Care Community. 2002;10(6):472–478.
  • Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17(5):427–442. doi:10.1212/WNL.17.5.4276067254
  • Higginson IJ, Gao W, Saleem TZ, et al. Symptoms and quality of life in late stage Parkinson syndromes: a longitudinal community study of predictive factors. PLoS One. 2012;7(11):e46327–e46327. doi:10.1371/journal.pone.004632723144781
  • Jenkinson C, Fitzptrick R, Peto V, Greenhall R, Hyman N. The PDQ-8: development and validation of a short-form parkinson’s disease questionnaire. Psychol Health. 1997;12(6):805–814. doi:10.1080/08870449708406741
  • Knipe MD, Wickremaratchi MM, Wyatt-Haines E, Morris HR, Ben-Shlomo Y. Quality of life in young-compared with late-onset Parkinson’s disease. Mov Disord. 2011;26(11):2011–2018. doi:10.1002/mds.2376321574185
  • Lawson RA, Yarnall AJ, Duncan GW, et al. Severity of mild cognitive impairment in early Parkinson’s disease contributes to poorer quality of life. Parkinsonism Relat Disord. 2014;20(10):1071–1075. doi:10.1016/j.parkreldis.2014.07.00425074728
  • Cubi-Molla P, de Vires J, Devlin N. A study of the relationship between health and subjective well-being in Parkinson’s disease patients. Value Health. 2014;17(4):372–379. doi:10.1016/j.jval.2014.03.00224968997
  • Murdock C, Cousins W, Kernohan WG. “Running water won’t freeze”: how people with advanced Parkinson’s disease experience occupation. Palliat Support Care. 2015;13(5):1363–1372. doi:10.1017/S147895151400135725543958
  • Jenkinson C, Dummett S, Kelly L, et al. The development and validation of a quality of life measure for the carers of people with Parkinson’s disease (the PDQ-Carer). Parkinsonism Relat Disord. 2012;18(5):483–487. doi:10.1016/j.parkreldis.2012.01.00722321866
  • Ware JE, Kosinski M, Keller SD. SF-12: How to Score the SF-12 Physical and Mental Health Summary Scales. 3rd ed. Lincoln: QualityMetric Incorporated; 1998.
  • Davey C, Wiles R, Ashburn A, Murphy C. Falling in Parkinson’s disease: the impact on informal caregivers. Disabil Rehabil. 2004;26(23):1360–1366.15742981
  • O’Reilly F, Finnan F, Allwright S, Smith G, Benshlomo Y. The effects of caring for a spouse with Parkinson’s disease on social, psychological and physical well-being. BrJ Gen Pract. 1996;46(410):507–512.8917868
  • Kudlicka A, Clare L, Hindle JV. Quality of life, health status and caregiver burden in Parkinson’s disease: relationship to executive functioning. Int J Geriatr Psychiatry. 2014;29(1):68–76. doi:10.1002/gps.397023625583
  • Peters M, Fitzpatrick R, Doll H, Playford D, Jenkinson C. Does self-reported well-being of patients with Parkinson’s disease influence caregiver strain and quality of life? Parkinsonism Relat Disord. 2011;17(5):348–352. doi:10.1016/j.parkreldis.2011.02.00921356603
  • Peters M, Jenkinson C, Doll H, Playford ED, Fitzpatrick R. Carer quality of life and experiences of health services: a cross-sectional survey across three neurological conditions. Health Qual Life Outcomes. 2013;11:103. doi:10.1186/1477-7525-11-10323800348
  • Drutyte G, Forjaz MJ, Rodriguez-Blazquez C, Martinez-Martin P, Breen KC. What impacts on the stress symptoms of Parkinson’s carers? Results from the Parkinson’s UK Members’ survey. Disabil Rehabil. 2014;36(3):199–204. doi:10.3109/09638288.2013.78236323586667
  • Morley D, Dummett S, Peters M, et al. Factors influencing quality of life in caregivers of people with Parkinson’s disease and implications for clinical guidelines. Parkinson’s Dis. 2012;2012:190901.23316414
  • Schrag A, Hovris A, Morley D, Quinn N, Jahanshahi M. Caregiver-burden in Parkinson’s disease is closely associated with psychiatric symptoms, falls, and disability. Parkinsonism Relat Disord. 2006;12(1):35–41. doi:10.1016/j.parkreldis.2005.06.01116271496
  • Schrag A, Morley D, Quinn N, Jahanshahi M. Impact of Parkinson’s disease on patients’ adolescent and adult children. Parkinsonism Relat Disord. 2004;10(7):391–397. doi:10.1016/j.parkreldis.2004.03.01115465394
  • Morley D, Selai C, Schrag A, Jahanshahi M, Thompson A. Adolescent and adult children of parents with Parkinson’s disease: incorporating their needs in clinical guidelines. Parkinson’s Dis. 2011;2011:951874. doi:10.4061/2011/15397921766002
  • National Institute of Health and Care Excellence. Parkinson’s Disease: National Clinical Guideline for Diagnosis and Management in Primary and Secondary Care CG35. London: Royal College of Physicians; 2006.
  • National Institute of Health and Care Excellence. Parkinson’s Disease in Adults. NG71. London: NICE; 2017.
  • Schrag A, Banks P. Time of loss of employment in Parkinson’s disease. Mov Disord. 2006;21(11):1839–1843. doi:10.1002/mds.2103016941456
  • Clarke C, Zobkiw R, Gullaksen E. Quality of life and care in Parkinson’s disease. Br J Clin Pract. 1995;49(6):288–293.8554950
  • Mclaughlin D, Hasson F, Kernohan WG, et al. Living and coping with Parkinson’s disease: perceptions of informal carers. Palliat Med. 2011;25(2):177–182. doi:10.1177/026921631038560420952448
  • McCrone P, Allcock LM, Burn DJ. Predicting the cost of Parkinson’s disease. Mov Disord. 2007;22(6):804–812. doi:10.1002/mds.2136017290462
  • Findley LJ, Wood E, Lowin J, Roeder C, Bergman A, Schifflers M. The economic burden of advanced Parkinson’s disease: an analysis of a UK patient dataset. J Med Econ. 2011;14(1):130–139. doi:10.3111/13696998.2010.55116421235405
  • Findley LJ. The economic impact of Parkinson’s disease. Parkinsonism Relat Disord. 2007;13:S8–S12. doi:10.1016/j.parkreldis.2007.06.00317702630
  • Low V, Ben-Shlomo Y, Coward E, Fletcher S, Walker R, Clarke CE. Measuring the burden and mortality of hospitalisation in Parkinson’s disease: a cross-sectional analysis of the English hospital episodes statistics database 2009–2013. Parkinsonism Relat Disord. 2015;21(5):449–454. doi:10.1016/j.parkreldis.2015.01.01725737205
  • Xin Y, Clarke CE, Muzerengi S, et al. Treatment reasons, resource use and costs of hospitalizations in people with Parkinson’s: results from a large RCT. Value Health. 2014;17(7):A809. doi:10.1016/j.jval.2014.08.541
  • Hobson P, Roberts S, Meara J. What is the economic utility of introducing a Parkinson’s disease nurse specialist service? Clinician (Goa). 2003;3:1–3.
  • Jarman B, Hurwitz B, Cook A, Bajekal M, Lee A. Effects of community based nurses specialising in Parkinson’s disease on health outcome and costs: randomised controlled trial. Bmj. 2002;324(7345):1072–1075. doi:10.1136/bmj.324.7345.107211991913
  • Hurwitz B, Jarman B, Cook A, Bajekal M. Scientific evaluation of community-based Parkinson’s disease nurse specialists on patient outcomes and health care costs. J Eval Clin Pract. 2005;11(2):97–110. doi:10.1111/j.1365-2753.2005.00495.x15813708
  • Walker R, Sweeney W, Gray W. Access to care services for rural dwellers with idiopathic Parkinson’s disease. Br J Neurosci Nurs. 2011;7(2):494–496. doi:10.12968/bjnn.2011.7.2.494
  • Findley L, Aujla M, Bain PG, et al. Direct economic impact of Parkinson’s disease: a research survey in the United Kingdom. Mov Disord. 2003;18(10):1139–1145. doi:10.1002/mds.1050714534917
  • Corbin CB, Pangrazi RP. Toward a Uniform definition of wellness: a commentary. President’s Counc Phys Fitness Sports. 2001;3(15):1–8.
  • Coster W. Making the best match: selecting outcome measures for clinical trials and outcome studies. Am J Occup Ther. 2013;67(2):162–170. doi:10.5014/ajot.2013.00601523433270
  • Eton DT, Elraiyah TA, Yost KJ, et al. A systematic review of patient-reported measures of burden of treatment in three chronic diseases. Patient Relat Outcome Meas. 2013;4:7–20. doi:10.2147/PROM23833553
  • Kelley K, Clarke B, Brown V, Sitzia J. Good practice in the conduct and reporting of survey research. Int J Qual Health Care. 2003;15(3):261–266. doi:10.1093/intqhc/mzg03112803354
  • Fahn S, Elton RL; UPDRS Program Members. Unified Parkinson’s disease rating scale In: Fahn S, Marsden CD, Goldstein M, Calne DB, editors. Recent Developments in Parkinson’s Disease, Vol. 2 Florham Park, NJ: Macmillan Healthcare Information; 1987:153–163, 293–304.
  • Allen E, Seaman C. Likert scales and data analysis. Qual Prog. 2007;40(7):64–65.
  • Dowding CH, Shenton CL, Salek SS. A review of the health-related quality of life and economic impact of Parkinson’s disease. Drugs Aging. 2006;23(9):693–721. doi:10.2165/00002512-200623090-0000117020395
  • Deane KHO, Flaherty H, Daley DJ, et al. Priority setting partnership to identify the top 10 research priorities for the management of Parkinson’s disease. BMJ Open. 2014;4(12):e006434. doi:10.1136/bmjopen-2014-006434
  • Moher D, Liberati A, Tetzlaff J,Altman DG, The PRISMA Group. Preferred reporting Items for systematic review and meta-analyses: the PRISMA Statement. PLoS Med. 2009;6(6): e1000097.19621072